Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simone Hettmer

Showing results (61-70 of 80) with videos related to

Pageof 8
Sort By:
Der Pathologe|December 1, 2020
[Diagnosis and therapy of tumors with NTRK gene fusion]Albrecht Stenzinger, Cornelis M van Tilburg, Ghazaleh Tabatabai, et al.
European Journal of Cancer (Oxford, England : 1990)|July 15, 2022
Molecular testing of rhabdomyosarcoma in clinical trials to improve risk stratification and outcome: A consensus view from European paediatric Soft tissue sarcoma Study Group, Children's Oncology Group and Cooperative Weichteilsarkom-StudiengruppeSimone Hettmer, Corinne M Linardic, Anna Kelsey, et al.
Oncology Research and Treatment|April 22, 2021
Utilization of Interdisciplinary Tumor Boards for Sarcoma Care in Germany: Results from the PROSa StudyMartin Eichler, Dimosthenis Andreou, Henriette Golcher, et al.
Cold Spring Harbor Perspectives in Medicine|November 5, 2014
Rhabdomyosarcoma: current challenges and their implications for developing therapiesSimone Hettmer, Zhizhong Li, Andrew N Billin, et al.
Geburtshilfe Und Frauenheilkunde|December 5, 2022
Sarcoma of the Uterus. Guideline of the DGGG, OEGGG and SGGG (S2k-Level, AWMF Registry No. 015/074, April 2021)Dominik Denschlag, Sven Ackermann, Marco Johannes Battista, et al.
Journal of Hematology & Oncology|August 16, 2022
Genotype-phenotype associations within the Li-Fraumeni spectrum: a report from the German RegistryJudith Penkert, Farina J Strüwe, Christina M Dutzmann, et al.
Geburtshilfe Und Frauenheilkunde|October 29, 2019
Sarcoma of the Uterus. Guideline of the DGGG and OEGGG (S2k Level, AWMF Register Number 015/074, February 2019)Dominik Denschlag, Sven Ackermann, Marco Johannes Battista, et al.
Geburtshilfe Und Frauenheilkunde|April 8, 2025
Sarcoma of the Uterus. Guideline of the DGGG, OEGGG and SGGG (S2k-Level, AWMF Registry No. 015/074, June 2024)Markus Wallwiener, Marco Johannes Battista, Eike-Christian Burandt, et al.
JCO Precision Oncology|September 11, 2020
Personalized Clinical Decision Making Through Implementation of a Molecular Tumor Board: A German Single-Center ExperienceRouven Hoefflin, Anna-Lena Geißler, Ralph Fritsch, et al.
European Journal of Cancer (Oxford, England : 1990)|October 31, 2020
Impact of COVID-19 in paediatric early-phase cancer clinical trials in Europe: A report from the Innovative Therapies for Children with Cancer (ITCC) consortiumAlba Rubio-San-Simón, Nicolas André, Maria Giuseppina Cefalo, et al.
Pageof 8

Showing results (61-70 of 80) with videos related to

Sort By:
Pageof 8
Der Pathologe|December 1, 2020
[Diagnosis and therapy of tumors with NTRK gene fusion]Albrecht Stenzinger, Cornelis M van Tilburg, Ghazaleh Tabatabai, et al.
European Journal of Cancer (Oxford, England : 1990)|July 15, 2022
Molecular testing of rhabdomyosarcoma in clinical trials to improve risk stratification and outcome: A consensus view from European paediatric Soft tissue sarcoma Study Group, Children's Oncology Group and Cooperative Weichteilsarkom-StudiengruppeSimone Hettmer, Corinne M Linardic, Anna Kelsey, et al.
Oncology Research and Treatment|April 22, 2021
Utilization of Interdisciplinary Tumor Boards for Sarcoma Care in Germany: Results from the PROSa StudyMartin Eichler, Dimosthenis Andreou, Henriette Golcher, et al.
Cold Spring Harbor Perspectives in Medicine|November 5, 2014
Rhabdomyosarcoma: current challenges and their implications for developing therapiesSimone Hettmer, Zhizhong Li, Andrew N Billin, et al.
Geburtshilfe Und Frauenheilkunde|December 5, 2022
Sarcoma of the Uterus. Guideline of the DGGG, OEGGG and SGGG (S2k-Level, AWMF Registry No. 015/074, April 2021)Dominik Denschlag, Sven Ackermann, Marco Johannes Battista, et al.
Journal of Hematology & Oncology|August 16, 2022
Genotype-phenotype associations within the Li-Fraumeni spectrum: a report from the German RegistryJudith Penkert, Farina J Strüwe, Christina M Dutzmann, et al.
Geburtshilfe Und Frauenheilkunde|October 29, 2019
Sarcoma of the Uterus. Guideline of the DGGG and OEGGG (S2k Level, AWMF Register Number 015/074, February 2019)Dominik Denschlag, Sven Ackermann, Marco Johannes Battista, et al.
Geburtshilfe Und Frauenheilkunde|April 8, 2025
Sarcoma of the Uterus. Guideline of the DGGG, OEGGG and SGGG (S2k-Level, AWMF Registry No. 015/074, June 2024)Markus Wallwiener, Marco Johannes Battista, Eike-Christian Burandt, et al.
JCO Precision Oncology|September 11, 2020
Personalized Clinical Decision Making Through Implementation of a Molecular Tumor Board: A German Single-Center ExperienceRouven Hoefflin, Anna-Lena Geißler, Ralph Fritsch, et al.
European Journal of Cancer (Oxford, England : 1990)|October 31, 2020
Impact of COVID-19 in paediatric early-phase cancer clinical trials in Europe: A report from the Innovative Therapies for Children with Cancer (ITCC) consortiumAlba Rubio-San-Simón, Nicolas André, Maria Giuseppina Cefalo, et al.
Pageof 8